PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 254 filers reported holding PACIRA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $491,000 | -98.2% | 10,311 | -98.7% | 0.05% | -96.2% |
| Q3 2016 | $26,638,000 | +12.3% | 778,442 | +10.7% | 1.22% | +10.7% |
| Q2 2016 | $23,714,000 | -38.9% | 703,054 | -4.1% | 1.10% | -39.7% |
| Q1 2016 | $38,828,000 | +9.6% | 732,887 | +58.8% | 1.83% | +19.8% |
| Q4 2015 | $35,432,000 | +55.6% | 461,422 | +80.1% | 1.53% | +91.1% |
| Q1 2015 | $22,767,000 | -54.2% | 256,244 | -54.3% | 0.80% | -55.3% |
| Q4 2014 | $49,667,000 | -33.3% | 560,200 | -27.1% | 1.79% | -32.0% |
| Q3 2014 | $74,472,000 | -16.2% | 768,396 | -20.6% | 2.63% | -7.6% |
| Q2 2014 | $88,887,000 | +5.8% | 967,638 | -19.4% | 2.85% | +14.2% |
| Q1 2014 | $84,004,000 | +73.4% | 1,200,229 | +42.4% | 2.50% | +86.1% |
| Q4 2013 | $48,446,000 | +211.9% | 842,702 | +160.9% | 1.34% | +200.7% |
| Q3 2013 | $15,534,000 | – | 323,027 | – | 0.45% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Key Colony Management, LLC | 134,600 | $13,045,000 | 11.31% |
| Biondo Investment Advisors, LLC | 279,717 | $27,110,000 | 8.33% |
| GILDER GAGNON HOWE & CO LLC | 3,177,130 | $307,927,000 | 4.48% |
| DARUMA CAPITAL MANAGEMENT LLC | 814,470 | $78,938,000 | 3.47% |
| MAGEE THOMSON INVESTMENT PARTNERS LLC | 126,022 | $12,214,000 | 3.01% |
| NEXT CENTURY GROWTH INVESTORS LLC | 768,396 | $74,472,000 | 2.63% |
| MARXE AUSTIN W & GREENHOUSE DAVID M | 180,000 | $17,446,000 | 2.38% |
| Lisanti Capital Growth, LLC | 48,280 | $4,679,000 | 2.35% |
| INSIGHT CAPITAL RESEARCH & MANAGEMENT INC | 79,017 | $7,658,000 | 2.00% |
| Atika Capital Management LLC | 21,500 | $2,084,000 | 1.60% |